Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Tassinari

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancerAlberto Ravaioli, Maurizio Marangolo, Enzo Pasquini, et al.
Journal of Translational Medicine|August 12, 2015
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trialPaola Ulivi, Emanuela Scarpi, Alessandro Passardi, et al.
Environmental Health Perspectives|January 6, 2010
Air pollution, aeroallergens, and emergency room visits for acute respiratory diseases and gastroenteric disorders among young children in six Italian citiesFlavia Orazzo, Luigi Nespoli, Kazuhiko Ito, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapyDavide Tassinari, Luigi Montanari, Marco Maltoni, et al.
Breast Cancer Research and Treatment|May 10, 2002
Staging of breast cancer: new recommended standard procedureAlberto Ravaioli, Giuseppe Pasini, Antonio Polselli, et al.
Therapeutic Advances in Medical Oncology|August 6, 2020
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trialElisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, et al.
Oncotargets and Therapy|September 15, 2018
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Elena Orlandi, et al.
Future Oncology (London, England)|May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of ItalyAlba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Scientific Reports|September 7, 2017
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trialAlessandro Passardi, Emanuela Scarpi, Fabio Gelsomino, et al.
Oncotarget|April 28, 2016
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancerAlessandro Passardi, Emanuela Scarpi, Luigi Cavanna, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancerAlberto Ravaioli, Maurizio Marangolo, Enzo Pasquini, et al.
Journal of Translational Medicine|August 12, 2015
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trialPaola Ulivi, Emanuela Scarpi, Alessandro Passardi, et al.
Environmental Health Perspectives|January 6, 2010
Air pollution, aeroallergens, and emergency room visits for acute respiratory diseases and gastroenteric disorders among young children in six Italian citiesFlavia Orazzo, Luigi Nespoli, Kazuhiko Ito, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapyDavide Tassinari, Luigi Montanari, Marco Maltoni, et al.
Breast Cancer Research and Treatment|May 10, 2002
Staging of breast cancer: new recommended standard procedureAlberto Ravaioli, Giuseppe Pasini, Antonio Polselli, et al.
Therapeutic Advances in Medical Oncology|August 6, 2020
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trialElisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, et al.
Oncotargets and Therapy|September 15, 2018
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Elena Orlandi, et al.
Future Oncology (London, England)|May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of ItalyAlba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Scientific Reports|September 7, 2017
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trialAlessandro Passardi, Emanuela Scarpi, Fabio Gelsomino, et al.
Oncotarget|April 28, 2016
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancerAlessandro Passardi, Emanuela Scarpi, Luigi Cavanna, et al.
Pageof 10